Weiqi Pan

机构：Macau University of Science and Technology, First Affiliated Hospital of Guangzhou Medical University, Guangdong Institute of Intelligent Manufacturing, Early Warning (United States), Guangzhou Medical University · ORCID：0009-0003-1989-4008

发表论文 66 篇 · 总被引 2084 次 · h-index 19

代表论文

• An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques (2020 · Nature Communications · 被引 248)
• Baloxavir marboxil use for critical human infection of avian influenza A H5N6 virus (2023 · Med · 被引 24)
• A decavalent composite mRNA vaccine against both influenza and COVID-19 (2024 · mBio · 被引 18)
• Towards broad-spectrum protection: the development and challenges of combined respiratory virus vaccines (2024 · Frontiers in Cellular and Infection Microbiology · 被引 14)
• Immunization with a Prefusion SARS-CoV-2 Spike Protein Vaccine (RBMRNA-176) Protects against Viral Challenge in Mice and Nonhuman Primates (2022 · Vaccines · 被引 14)
• Pathogenesis of influenza and SARS-CoV-2 co-infection at the extremes of age: decipher the ominous tales of immune vulnerability (2025 · Advanced Biotechnology · 被引 11)